Opioid-induced constipation can be a frustrating and debilitating side effect of pain management. Fortunately, medical professionals now have access to naloxegol, a medication that specifically targets this issue. In this comprehensive guide, we'll unpack everything you need to know about naloxegol, including its pros and cons, potential side effects, and cost. By the end of this article, you'll have a thorough understanding of how naloxegol works and whether it's the right treatment option for your patients with opioid-induced constipation. So let's dive in!
Naloxegol, also known as Movantik, is a medication used to treat opioid-induced constipation. While it has been proven effective in relieving constipation symptoms caused by opioids, like any other medication, it has its pros and cons.
One of the main advantages of Naloxegol is that it works by blocking the opioid receptors in the gut without affecting pain relief. This means that patients can continue taking their prescribed opioids while also managing their constipation symptoms.
Another advantage is that Naloxegol has a lower risk of abuse than other medications for constipation relief because it does not produce a high or euphoric effect.
On the downside, some common side effects of Naloxegol include abdominal pain, diarrhea, nausea, vomiting and headaches. In rare cases, patients may experience severe allergic reactions which require immediate medical attention.
Another disadvantage is that Naloxegol should be used with caution in patients with liver problems or those taking medications metabolized by CYP3A4 enzymes because it may increase drug levels in the blood leading to potential adverse drug interactions.
Naloxegol is an effective medication for treating opioid-induced constipation, but like any other drug, it comes with potential side effects. While most patients tolerate naloxegol well, some may experience adverse reactions.
One of the most common side effects of Naloxegol is nausea. Patients may feel queasy and uncomfortable after taking the medication. Other gastrointestinal symptoms like diarrhea, vomiting and abdominal pain have also been reported in some cases.
In rare instances, naloxegol can lead to severe allergic reactions such as hives or swelling of the face. In case this happens to a patient, immediate medical attention should be sought.
Some people may also experience headaches while using naloxegol. Dizziness and fatigue are other possible side effects that could affect daily activities.
Naloxegol is a promising medication for managing opioid-induced constipation in patients who are not responding well to other laxatives. It has been shown to be effective and generally safe with few side effects.
As medical professionals, it is important to understand the pros and cons of using naloxegol as part of our treatment strategies. We must monitor our patients closely for any potential side effects and educate them on how to properly use the medication.
Naloxegol offers another option for managing opioid-induced constipation and can greatly improve the quality of life for those suffering from this condition.
1.
Even when they are not paying attention, children are still learning.
2.
Study finds higher breast cancer rates in areas with more air pollution
3.
MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC
4.
New Zealand and Australian breast cancer rates among the highest in the world, global study finds
5.
PET-CT finds further-reaching metastases in patients with locally advanced breast cancer.
1.
Case-Based Learning on Functional Bone Marrow Recovery Following Sequential Immune Challenges
2.
Understanding Cold Agglutinin Disease: Symptoms, Diagnosis, and Treatment Options
3.
Understanding Sickle Cell Anemia: Causes, Symptoms, and Treatment Options
4.
Beyond the Human Eye: How AI Is Redefining Brain Cancer Diagnosis Through Advanced Imaging
5.
ctDNA in Oncology: Transforming MRD Assessment, Disease Tracking, and Early Cancer Detection
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Updates on Standard V/S High Risk Myeloma Treatment
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
5.
Understanding Cancer: Early Detection and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation